Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance

Date: 07/13/2021

Product type: Drugs, Potential Lack of Sterility

Company Announcement Date: July 12, 2021
FDA Publish Date: July 13, 2021
Product Type: Drugs
Reason for Announcement: Potential lack of sterility assurance
Company Name: Innoveix Pharmaceuticals, Inc.
Brand Name: Innoveix Pharmaceuticals, Inc.
Product Description: Injectable Semorelin / Ipamorelin 3mg and injectable AOD-9604 3mg

US-FDA Link: